{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T00:20:19Z","timestamp":1777681219474,"version":"3.51.4"},"reference-count":18,"publisher":"SAGE Publications","issue":"6","license":[{"start":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T00:00:00Z","timestamp":1594598400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Hosp Pharm"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:p>\n                    <jats:bold>Objective:<\/jats:bold>\n                    A 15-year-old pediatric male patient was influenza A positive and started on oseltamivir at an outpatient clinic.\n                    <jats:bold>Method:<\/jats:bold>\n                    The next morning the patient presented to the emergency department (ED) with a chief complaint of visual disturbances including decreased central vision. Prior to presenting to the ED the patient was evaluated by his optometrist and his eye exam tested 20\/400 bilaterally. His previous year\u2019s eye exam was normal, 20\/25 bilaterally.\n                    <jats:bold>Results:<\/jats:bold>\n                    In the ED, the patient had an MRI which showed a normal appearing optic nerve, chiasm, and optic tracts. The oseltamivir therapy was discontinued, and the patient followed up with an ophthalmologist outpatient.\n                    <jats:bold>Conclusion:<\/jats:bold>\n                    At a 10-week follow-up visit the patient had 90% recovery of his vision.\n                  <\/jats:p>","DOI":"10.1177\/0018578720942225","type":"journal-article","created":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T17:21:58Z","timestamp":1594660918000},"page":"678-680","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":2,"title":["Temporary Central Vision Blindness After Oseltamivir Administration in a 15-Year-Old Pediatric Male Positive for Influenza A"],"prefix":"10.1177","volume":"56","author":[{"given":"Laura","family":"Carson","sequence":"first","affiliation":[{"name":"Stormont-Vail Healthcare, Topeka, KS, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4363-6976","authenticated-orcid":false,"suffix":"II","given":"John E.","family":"Price","sequence":"additional","affiliation":[{"name":"Stormont-Vail Healthcare, Topeka, KS, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2020,7,13]]},"reference":[{"key":"e_1_3_2_2_2","unstructured":"Budd A Blanton L Grohskopf L et al. Chapter 6: influenza manual for the surveillance of vaccine-preventable diseases. In: Roush SW Baldy LM Kirkconnell Hall MA. Manual for the Surveillance of Vaccine-Preventable Diseases. Atlanta: Centers for Disease Control and Prevention. Published November 10 2017. Accessed March 9 2020. https:\/\/www.cdc.gov"},{"issue":"3","key":"e_1_3_2_3_2","first-page":"171","article-title":"Reversible blindness in bilateral optic neuritis associated with nasal flu vaccine","volume":"27","author":"Crawford C","year":"2012","unstructured":"Crawford C, Grazko MB, Raymond WR, et al. Reversible blindness in bilateral optic neuritis associated with nasal flu vaccine. Binocul Vis Strabolog Q Simms Romano. 2012;27(3):171-173.","journal-title":"Binocul Vis Strabolog Q Simms Romano"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajoc.2018.02.008"},{"issue":"2","key":"e_1_3_2_5_2","first-page":"118","article-title":"Early onset optic neuritis following measles-rubella vaccination","volume":"3","author":"Moradian S","year":"2008","unstructured":"Moradian S, Ahmadieh H. Early onset optic neuritis following measles-rubella vaccination. J Opthalmic Vis Res. 2008;3(2):118-122.","journal-title":"J Opthalmic Vis Res"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1159\/000083273"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1080\/01658107.2017.1335333"},{"key":"e_1_3_2_8_2","unstructured":"Mayo Clinic. Oseltamivir (oral route). Published February 1 2020. Accessed March 9 2020. https:\/\/www.mayoclinic.org"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.4103\/jovr.jovr_200_15"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/IJG.0000000000000270"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.4103\/0301-4738.109531"},{"issue":"102","key":"e_1_3_2_12_2","first-page":"167","article-title":"Oseltamivir: cardiac and visual disorders: add-on toxicity","volume":"18","author":"Prescrire Editorial Staff","year":"2009","unstructured":"Prescrire Editorial Staff. Oseltamivir: cardiac and visual disorders: add-on toxicity. Prescrire Int. 2009;18(102):167.","journal-title":"Prescrire Int"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2007.08.054"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.9758\/cpn.2015.13.2.209"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-012-0050-8"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.4103\/jpp.JPP_121_17"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.154"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1080\/09273948.2019.1681470"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/698256"}],"container-title":["Hospital Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0018578720942225","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/0018578720942225","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0018578720942225","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T08:39:20Z","timestamp":1777451960000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/0018578720942225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,13]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["10.1177\/0018578720942225"],"URL":"https:\/\/doi.org\/10.1177\/0018578720942225","relation":{},"ISSN":["0018-5787","1945-1253"],"issn-type":[{"value":"0018-5787","type":"print"},{"value":"1945-1253","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,13]]}}}